quinazolines has been researched along with Plasmodium falciparum Malaria in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Athanassopoulos, CM; Baltas, M; Koumpoura, CL; Robert, A | 1 |
| Arimondo, PB; Bozdech, Z; Claës, A; Dobrescu, I; Dziekan, JM; Halby, L; Hammam, E; Nardella, F; Preiser, P; Scherf, A | 1 |
| Farrukh, A; Kiesow, MJ; Llinás, M; Ngwa, CJ; Orchard, LM; Pradel, G | 1 |
| Jain, V; Kikuchi, H; Oshima, Y; Sharma, A; Yogavel, M | 1 |
| Angulo-Barturen, I; Avery, VM; Caron, J; Chen, P; Delves, MJ; Duffy, S; Ferrer, S; Fuchter, MJ; Gamo, FJ; Jiménez-Díaz, MB; Malmquist, NA; Menard, D; Nosten, F; Renia, L; Ruecker, A; Santos Martínez, M; Sanz, LM; Scherf, A; Sinden, RE; Sundriyal, S; Suwanarusk, R; Witkowski, B; Wittlin, S | 1 |
| Chen, Q; Deitsch, KW; Heinberg, AR; Ukaegbu, UE; Wele, M; Zhang, X | 1 |
| Bopp, SE; Clardy, J; Clish, CB; Cortese, JF; Derbyshire, ER; Estiu, G; Galinsky, K; Herman, JD; Keller, TL; Lindquist, S; Lukens, AK; Mazitschek, R; Mota, MM; Patel, V; Pepper, LR; Ribacke, U; Santos, SA; Schimmel, P; Sullivan, WJ; Whitman, M; Wiest, O; Wirth, DF; Zhou, H; Zuzarte-Luis, V | 1 |
| Brun, R; Chitnumsub, P; Dartois, V; Diagana, TT; Goh, A; Kamchonwongpaisan, S; Keller, TH; Kiara, SM; Lakshminarayana, SB; Ma, NL; Maneeruttanarungroj, C; Nzila, A; Rottmann, M; Taweechai, S; Weaver, M; Wittlin, S; Wong, J; Yeung, BK; Yuthavong, Y; Zou, B | 1 |
| Mital, A | 1 |
2 review(s) available for quinazolines and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Antimalarial Inhibitors Targeting Epigenetics or Mitochondria in
Topics: Animals; Antimalarials; Dihydroorotate Dehydrogenase; DNA; Drug Discovery; Drug Resistance; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylases; Humans; Malaria, Falciparum; Methyltransferases; Mitochondria; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium falciparum; Quinazolines; Signal Transduction; Structure-Activity Relationship | 2021 |
Recent advances in antimalarial compounds and their patents.
Topics: Animals; Antimalarials; Artemisinins; Folic Acid Antagonists; Humans; Malaria, Falciparum; Patents as Topic; Plasmodium falciparum; Quinazolines; Quinolines | 2007 |
7 other study(ies) available for quinazolines and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Topics: Animals; Antimalarials; Humans; Life Cycle Stages; Malaria; Malaria, Falciparum; Plasmodium falciparum; Prokaryotic Initiation Factor-3; Quinazolines; Quinolines | 2023 |
The G9a Histone Methyltransferase Inhibitor BIX-01294 Modulates Gene Expression during
Topics: Animals; Anopheles; Antimalarials; Azepines; Gene Expression Regulation, Developmental; Germ Cells; Histone-Lysine N-Methyltransferase; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinazolines | 2019 |
Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase.
Topics: Amino Acyl-tRNA Synthetases; Antimalarials; Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Malaria, Falciparum; Piperidines; Plasmodium falciparum; Protozoan Proteins; Quinazolines | 2014 |
Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.
Topics: Animals; Antimalarials; Azepines; Female; Hep G2 Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Malaria; Malaria, Falciparum; Mice; Mice, SCID; Plasmodium berghei; Plasmodium falciparum; Quinazolines | 2015 |
A Unique Virulence Gene Occupies a Principal Position in Immune Evasion by the Malaria Parasite Plasmodium falciparum.
Topics: Antigenic Variation; Antigens, Protozoan; Azepines; Chloroquine; Gene Expression Regulation; Genetic Loci; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Hydroxamic Acids; Immune Evasion; Inhibitory Concentration 50; Malaria, Falciparum; Models, Theoretical; Piperazines; Plasmodium falciparum; Promoter Regions, Genetic; Protozoan Proteins; Quinazolines; RNA Polymerase II; Terpenes; Transcriptional Activation; Transcriptome | 2015 |
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
Topics: Amino Acyl-tRNA Synthetases; Animals; Antimalarials; Computer-Aided Design; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Resistance; Enzyme Inhibitors; Erythrocytes; Liver; Malaria, Falciparum; Mice; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Piperidines; Plasmodium falciparum; Protozoan Proteins; Quinazolines; Quinazolinones; Structure-Activity Relationship; Time Factors | 2015 |
Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate.
Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Drug Resistance; Female; Folic Acid Antagonists; Humans; In Vitro Techniques; Malaria; Malaria, Falciparum; Male; Mice; Models, Molecular; Mutation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinazolines; Rats; Rats, Wistar; Tetrahydrofolate Dehydrogenase | 2010 |